• Fighting for Patient Access, Affordability, and Transparency in Health Care
Patients Rising Now
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • Terry’s Hot Takes
    • News and Insights
    • Position Statements
    • Policy Supported
  • Get Involved
    • Take Action
    • Virtual Advocacy Chat
    • Events
    • Advocacy Toolkit
    • Advocacy Master Class
  • Donate
Select Page
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • Terry’s Hot Takes
    • News and Insights
    • Position Statements
    • Policy Supported
  • Get Involved
    • Take Action
    • Virtual Advocacy Chat
    • Events
    • Advocacy Toolkit
    • Advocacy Master Class
  • Donate
Patients Rising Podcast Episode 26: Calculating the Value of Patient Lives

Patients Rising Podcast Episode 26: Calculating the Value of Patient Lives

Aug 22, 2020 | Featured, ICER, Podcast, QALY

On this week’s episode of the podcast, Terry and Bob discuss how a Boston nonprofit called the Institute for Clinical and Economic Review (ICER) threatens healthcare for millions of Americans with chronic diseases.  Terry and Bob discussed the pernicious...
Read more
“Cures will become the norm” over the next decade – due to life sciences innovation

“Cures will become the norm” over the next decade – due to life sciences innovation

Jan 24, 2020 | ICER, Issues, News

Over the next decade, patients living with chronic conditions and rare diseases can expect groundbreaking new treatments, one-time cures and personalized therapies, a new report by the leading experts in the life sciences predicts. “Cures will become the norm, not the...
Read more

A dangerous plan for rationing essential prescription drugs

Aug 6, 2019 | ICER, News, QALY

The midterms are over and it’s time to get back to discussing issues that impact Americans on a daily basis. Things like health care and, specifically how to reduce costs. President Trump has made lowering the cost of prescription drugs one of his priorities. It seems...
Read more

Categories

  • Access
  • Actions
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • Featured
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Issues
  • Letters Submitted
  • Letters Supported
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • QALY
  • State Issues
  • Step Therapy
  • Terry's Hot Takes
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

340B Access to Care Biden Administration Cancer chemo drugs cms Copay Accumulators copay assistance COVID-19 Vaccine DPC drug costs drug discount programs Drug Importation Drug Manufacturing Drug Pricing drug rebate Elizabeth Warren fail first Health Insurance hospital bills HR 3708 hsa ICER Imported Drugs Insurance design Joe Biden Lupus Medicaid medicare Part B medicare part D Nonmedical Switching open enrollment out of Out of Pocket Costs Patient Access Patients Assitance PBM pharmacy benefit managers Preexisting Conditions Price Transparency Prior Authorization QALY Step Therapy transparency Value Framework

Recent Posts

  • Season 2 | Episode 15 – My Life is Worth It!
  • The American Rescue Plan Brings Promise of Expanded Access to Healthcare and Reduced Costs
  • Season 2 | Episode 14: Why Your Care Costs So Much
  • Virtual Advocacy Chat: Healthcare Inequities and Barriers within the Minority Community
  • Inpatient or Outpatient Care? CMS Savings Will Burden Patient Pockets

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

Patients Rising Now

11710 Plaza America Drive
Suite 200
Reston, VA 20109
  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2021 Patients Rising Now